# Mesenchymal Stromal Cells in Kidney Transplant Recipients

> **NCT02012153** · PHASE1 · TERMINATED · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 3 (actual)

## Conditions studied

- Kidney Transplant Rejection

## Interventions

- **BIOLOGICAL:** Mesenchymal Stromal Cells

## Key facts

- **NCT ID:** NCT02012153
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-12-04
- **Primary completion:** 2023-05-29
- **Final completion:** 2023-05-29
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Failure to enroll the number of patients required by the protocol due to the low number of living donor transplants performed at the Clinical Center
- **Last updated:** 2023-06-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02012153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02012153, "Mesenchymal Stromal Cells in Kidney Transplant Recipients". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02012153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*